Early Statins after Intravenous or Endovascular Recanalization Is Beneficial Regardless of Timing, Intensity, and Stroke Mechanism
Han-Gil Jeong, Beom Joon Kim, Mi Hwa Yang, Moon-Ku Han, Hee-Joon Bae
J Stroke. 2017;19(3):370-372.   Published online 2017 Sep 29     DOI: https://doi.org/10.5853/jos.2017.00836
Citations to this article as recorded by Crossref logo
Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
Yoonkyung Chang, Soojeong Eom, Minjeong Kim, Tae-Jin Song
Medicina.2023; 59(4): 776.     CrossRef
Management of Dyslipidemia after Stroke
Yoon kyung Chang, Tae-Jin Song
Journal of the Korean Neurological Association.2022; 40(3): 217.     CrossRef
Control of dyslipidemia in the prevention of recurrent ischemic cerebrovascular accidents (expert opinion)
M. M. Tanashyan, N. A. Shamalov, I. A. Voznyuk, S. N. Yanishevsky, O. I. Vinogradov, D. R. Khasanova, O. V. Tikhomirova, V. A. Parfenov, E. V. Oshchepkova, M. V. Ezhov, V. S. Gurevich, V. V. Arkhipov
Neurology, Neuropsychiatry, Psychosomatics.2022; 14(4): 108.     CrossRef
Statins in patients with acute ischemic stroke: when we should start therapy?
S. N. Yanishevskiy, I. B. Skiba, A. Y. Polushin
"Arterial’naya Gipertenziya" ("Arterial Hypertension").2021; 27(1): 16.     CrossRef
Clinical significance of serum-terminal pro-B-type natriuretic peptide in patients with acute cerebral stroke
Qi Yang, Chang Li, Le Wang, Bo Wei
Panminerva Medica.2018;[Epub]     CrossRef